And Boston Beer Co.

Why This Traditional Brokerage Firm Is Betting Big On Cannabis Even though there is not a ton of investable assets in cannabis, per se, I do cover Molson Coors and Constellation Brands and Brown-Forman and those are Medical marijuana names that institutional investors really care about, she told Bloomberg. Azer. who is the first senior Wall Street analyst to cover the cannabis sector, says the SEC regulator filings of Brown-Forman Corp. and Boston Beer Co. state that the cannabis industry is a potential risk factor for their growth. And as Azers told Bloomberg, her research suggests that the concern is warranted: Beer isnt selling as well in states where recreational pot is legal. And its not just the United States market that is drawing interest from institutional investors; there is a lot of attention being focused north of the border. Earlier this week, Cowen released O Cannabis!: Initiating Coverage of Canadian Cannabis, a 23-page report examining the first major developed market to legalize cannabis for adult use nationally. Azer anticipates the Canadian market could generate $8 billion in sales revenue by 2021. The U.S.

To read more visit

Comments are closed.